Australia markets closed

The Beauty Health Company (SKIN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2300-0.0100 (-0.31%)
At close: 04:00PM EDT
3.1345 -0.10 (-2.96%)
Pre-market: 09:05AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 398.77M
Enterprise value 628.04M
Trailing P/E N/A
Forward P/E 35.84
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.07
Price/book (mrq)6.71
Enterprise value/revenue 1.58
Enterprise value/EBITDA -11.21

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-69.38%
S&P500 52-week change 324.19%
52-week high 311.2900
52-week low 31.3500
50-day moving average 33.6300
200-day moving average 34.4207

Share statistics

Avg vol (3-month) 32.48M
Avg vol (10-day) 31.35M
Shares outstanding 5123.46M
Implied shares outstanding 6123.81M
Float 870.35M
% held by insiders 110.02%
% held by institutions 197.65%
Shares short (15 Apr 2024) 410.27M
Short ratio (15 Apr 2024) 45.01
Short % of float (15 Apr 2024) 420.30%
Short % of shares outstanding (15 Apr 2024) 48.32%
Shares short (prior month 15 Mar 2024) 412M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -25.16%
Operating margin (ttm)-18.96%

Management effectiveness

Return on assets (ttm)-8.47%
Return on equity (ttm)-88.43%

Income statement

Revenue (ttm)397.99M
Revenue per share (ttm)3.02
Quarterly revenue growth (yoy)-1.30%
Gross profit (ttm)N/A
EBITDA -96.24M
Net income avi to common (ttm)-100.12M
Diluted EPS (ttm)-0.7600
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)523.02M
Total cash per share (mrq)4.24
Total debt (mrq)752.29M
Total debt/equity (mrq)1,266.69%
Current ratio (mrq)6.07
Book value per share (mrq)0.48

Cash flow statement

Operating cash flow (ttm)21.75M
Levered free cash flow (ttm)24.91M